{"transactions":[{"id":897479,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:11.000Z","date":"2026-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":2446,"price":1.89,"value":4622.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":336910,"source":{"system":"sec-edgar","filing":"0001470831-26-000179","document":"wk-form4_1771452309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000147083126000179/wk-form4_1771452309.xml","form_type":"4"}},{"id":897478,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:11.000Z","date":"2026-02-14","kind":"exercise","planned":false,"acquired":true,"shares":7050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of RSUs. The grant of RSUs was initially reported in Table I of the Forms 4 filed by the Reporting Person on February 18, 2025."}],"balance_after":339356,"source":{"system":"sec-edgar","filing":"0001470831-26-000179","document":"wk-form4_1771452309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000147083126000179/wk-form4_1771452309.xml","form_type":"4"}},{"id":897477,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-18T17:05:11.000Z","date":"2026-02-13","kind":"grant","planned":false,"acquired":true,"shares":240000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest as follows: (i) 120,000 RSUs shall vest in three equal annual installments following the grant date, with the first installment vesting on February 13, 2027, and (ii) 120,000 RSUs shall vest in full on February 13, 2029, subject to potential acceleration upon achievement of certain performance milestones."}],"balance_after":339356,"source":{"system":"sec-edgar","filing":"0001470831-26-000179","document":"wk-form4_1771452309.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000147083126000179/wk-form4_1771452309.xml","form_type":"4"}},{"id":1011458,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-30T16:30:04.000Z","date":"2025-10-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":5644,"price":2.58,"value":14561.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs and does not represent a sale by the Reporting Person."}],"balance_after":99356,"source":{"system":"sec-edgar","filing":"0001193125-25-258664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000119312525258664/ownership.xml","form_type":"4"}},{"id":1011457,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-10-30T16:30:04.000Z","date":"2025-10-28","kind":"exercise","planned":false,"acquired":true,"shares":19200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition of shares of Common Stock upon vesting of a previously disclosed grant of restricted stock units (\"RSUs\"). The grant of RSUs was initially reported in Table I of the Form 4 filed by the Reporting Person on October 28, 2024."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001193125-25-258664","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000119312525258664/ownership.xml","form_type":"4"}},{"id":1264398,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-18T16:54:38.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":42400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying this option shall vest and become exercisable in forty-eight equal monthly installments following the grant date, with the first installment vesting on March 14, 2025."}],"balance_after":42400,"derivative":{"exercise_price":3.18,"expiration_date":"2035-02-13","underlying":"Common Stock","underlying_shares":42400},"source":{"system":"sec-edgar","filing":"0001662579-25-000015","document":"wk-form4_1739915672.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000166257925000015/wk-form4_1739915672.xml","form_type":"4"}},{"id":1264397,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-02-18T16:54:38.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":28200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on February 14, 2026."}],"balance_after":105000,"source":{"system":"sec-edgar","filing":"0001662579-25-000015","document":"wk-form4_1739915672.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000166257925000015/wk-form4_1739915672.xml","form_type":"4"}},{"id":1380165,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-29T16:31:32.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":345600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares underlying this option shall vest and become exercisable on October 28, 2025, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":345600,"derivative":{"exercise_price":6,"expiration_date":"2034-10-27","underlying":"Common Stock","underlying_shares":345600},"source":{"system":"sec-edgar","filing":"0001662579-24-000094","document":"wk-form4_1730233884.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000166257924000094/wk-form4_1730233884.xml","form_type":"4"}},{"id":1380164,"issuer":{"id":5503,"kind":"organization","name":"C4 Therapeutics, Inc.","symbol":"CCCC"},"owners":[{"id":65942,"kind":"person","name":"Mahaney Paige","position":1,"cik":"0002040313","reported_name":"Mahaney Paige","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-10-29T16:31:32.000Z","date":"2024-10-28","kind":"grant","planned":false,"acquired":true,"shares":76800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. The RSUs shall vest in four equal annual installments following the grant date, with the first installment vesting on October 28, 2025, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":76800,"source":{"system":"sec-edgar","filing":"0001662579-24-000094","document":"wk-form4_1730233884.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2040313/000166257924000094/wk-form4_1730233884.xml","form_type":"4"}}]}